Klobuchar Statement on Newly Released Prices for 15 Additional Prescription Drugs Subject to Medicare Negotiations
last year; 48% lower for Xtandi, which treats prostate cancer and was taken by 35,000 Medicare Part
Full-text search across every press release in the archive. Matches the title and body, with English stemming, “vote” catches “voted” and “voting.”
2 results for “prostate” · Minnesota
last year; 48% lower for Xtandi, which treats prostate cancer and was taken by 35,000 Medicare Part
Part D program; Xtandi, which treats prostate cancer and was taken by 35,000 Medicare Part D beneficiaries